
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers
Dimos D. Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1179-1179
Open Access | Times Cited: 11
Dimos D. Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1179-1179
Open Access | Times Cited: 11
Showing 11 citing articles:
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
G. Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 31-39
Open Access | Times Cited: 40
G. Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 31-39
Open Access | Times Cited: 40
Vaccine Hesitancy among Healthcare Workers in Europe: A Systematic Review
Mandeep Kaur, Luca Coppeta, Ole F. Olesen
Vaccines (2023) Vol. 11, Iss. 11, pp. 1657-1657
Open Access | Times Cited: 13
Mandeep Kaur, Luca Coppeta, Ole F. Olesen
Vaccines (2023) Vol. 11, Iss. 11, pp. 1657-1657
Open Access | Times Cited: 13
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
Evrydiki Kravvariti, Maria‐Iosifina Kasdagli, Konstantina Maria Diomatari, et al.
Osteoporosis International (2023) Vol. 34, Iss. 3, pp. 585-598
Closed Access | Times Cited: 6
Evrydiki Kravvariti, Maria‐Iosifina Kasdagli, Konstantina Maria Diomatari, et al.
Osteoporosis International (2023) Vol. 34, Iss. 3, pp. 585-598
Closed Access | Times Cited: 6
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals
Elena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 439-439
Open Access | Times Cited: 9
Elena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 439-439
Open Access | Times Cited: 9
Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?–A Danish national cohort study
Kristoffer Torp Hansen, Fiona Kusk Povlsen, Bodil Hammer Bech, et al.
Public Health (2024) Vol. 237, pp. 299-306
Open Access | Times Cited: 1
Kristoffer Torp Hansen, Fiona Kusk Povlsen, Bodil Hammer Bech, et al.
Public Health (2024) Vol. 237, pp. 299-306
Open Access | Times Cited: 1
Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis
Cosby A. Stone, Lene H. Garvey, Shuaib Nasser, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2008-2022
Open Access | Times Cited: 4
Cosby A. Stone, Lene H. Garvey, Shuaib Nasser, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2008-2022
Open Access | Times Cited: 4
Vaccination Hesitancy among Health-Care-Workers in Academic Hospitals Is Associated with a 12-Fold Increase in the Risk of COVID-19 Infection: A Nine-Month Greek Cohort Study
Fotinie Ntziora, Evangelia Georgia Kostaki, Ioannis Grigoropoulos, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 26-26
Open Access | Times Cited: 7
Fotinie Ntziora, Evangelia Georgia Kostaki, Ioannis Grigoropoulos, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 26-26
Open Access | Times Cited: 7
Understanding the Challenges of Intensive Care Staff in Communicating With Patients and Patients’ Families During the COVID-19 Crisis: A Qualitative Exploration
Manjulika Vaz, Carol D'Silva, Bhuvana Krishna, et al.
Cureus (2023)
Open Access | Times Cited: 2
Manjulika Vaz, Carol D'Silva, Bhuvana Krishna, et al.
Cureus (2023)
Open Access | Times Cited: 2
The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect
Martina Amanzio, Giuseppina Elena Cipriani, Dimos D. Mitsikostas
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1377-1382
Closed Access | Times Cited: 3
Martina Amanzio, Giuseppina Elena Cipriani, Dimos D. Mitsikostas
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1377-1382
Closed Access | Times Cited: 3
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials
Maria P. Yavropoulou, Maria‐Iosifina Kasdagli, Polyzois Makras, et al.
Maturitas (2023) Vol. 179, pp. 107874-107874
Closed Access | Times Cited: 1
Maria P. Yavropoulou, Maria‐Iosifina Kasdagli, Polyzois Makras, et al.
Maturitas (2023) Vol. 179, pp. 107874-107874
Closed Access | Times Cited: 1
Impact of Media Information in the Development of Novel Coronavirus Symptoms without the Disease: Nocebo Phenomenon
Vinanthi Hegde, N. Maheshbabu
International Neuropsychiatric Disease Journal (2022), pp. 29-37
Open Access
Vinanthi Hegde, N. Maheshbabu
International Neuropsychiatric Disease Journal (2022), pp. 29-37
Open Access